Altimmune
ALT
NASDAQ
IPO2005
about ALT
Altimmune develops vaccines and immunotherapies targeting infectious diseases such as COVID-19, with a focus on innovative prevention and treatment solutions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.08 | $4.18 | $3.86 | $426.76M | 5.64M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.21 | n/a | 70997.91 | -417180.00% | -380280.00% | 0% |